Diamines & Chemicals Limited received trading approval from BSE Limited and National Stock Exchange of India Limited for 2,69,402 equity shares allotted pursuant to the conversion of warrants issued on a preferential basis. The shares were listed and admitted to dealings on both exchanges starting June 12, 2026. This development increases the listed capital of the company to ₹10,05,33,920, comprising 1,00,53,392 fully paid equity shares of ₹10 each.

The approval follows applications submitted to the exchanges, with NSE issuing letter reference NSE/LIST/55629 and BSE issuing reference LOD / PREF / SV / 247/2026-2027, both dated June 11, 2026. The equity shares, bearing distinctive numbers from 9783991 to 10053392, were issued at a premium of ₹542 per share to promoters and non-promoters.

Lock-in Details

A portion of the newly issued shares is subject to a lock-in period as per regulatory requirements. The schedule ensures stability for the shares issued to promoters.

Regulatory Disclosures

The company provided the disclosures under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, regarding the granting of key licenses or regulatory approvals. The trading approval allows the company to commence trading of the converted warrants, thereby expanding its equity base in the market.

The Board of Directors of Diamines & Chemicals Limited, at its meeting held on May 18, 2026, approved the reappointment of key directors and the appointment of statutory auditors for the financial year 2026-27. These decisions are subject to the approval of the members where required.

Director Reappointments

The Board approved the reappointment of Mr. Tanmay Godiawala (DIN: 07084668) as Executive Director for a term of three years with effect from February 06, 2027. Mr. Godiawala holds an MSc in Chemical Process Research and Development from the University of Leeds, UK, and possesses over 15 years of experience in R&D, scale-up, technical sales, and marketing. He is currently the Managing Director of DACL Fine Chem Limited, a wholly owned subsidiary.

Mr. Rajendra Chhabra (DIN: 00093384) was reappointed as a Non-Executive Director in the category of Professional Director for a term of three years effective November 06, 2026. A Practicing Chartered Accountant, Mr. Chhabra has been associated with the company since 2001 and plays a significant role in finance functions. The Board also approved remuneration payable to Mr. Chhabra and commission on net profits for Non-Executive Directors for FY 2026-27 to FY 2030-31, subject to member approval.

Auditor Appointments

The Board appointed the following auditors for the financial year 2026-27:

M/s S S Puranik & Associates, a firm of Cost Accountants, was reappointed as Cost Auditor. M/s CNK & Associates LLP, a Chartered Accountant firm with experience in the chemical sector, was appointed as Internal Auditor. M/s K. C. Mehta & Co. LLP, the existing Statutory Auditors, were appointed as Tax Auditors.